British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription information for its Omjjara drug, an industry self-regulatory body said on ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.

A doctor and a patient discussing a therapy plan that includes pharmaceutical products. A caller asked if Cramer deviated from his previous bullishness on GSK plc (NYSE:GSK), in light of the ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other most ...

Bullish option flow detected in GSK (GSK) Pharma with 5,714 calls trading, 4x expected, and implied vol increasing over 5 points to 42.48%. Apr-25 38 calls and 4/4 weekly 37 puts are the most active ...

The 2022 edition of the Access to Medicine Index (ATMI) – which places the top 20 pharma companies for their efforts to improve delivery of medicines to lower income countries – sees GSK ...

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.